FDA — authorised 24 September 1996
- Application: NDA020533
- Marketing authorisation holder: FRESENIUS KABI USA
- Local brand name: NAROPIN
- Indication: SOLUTION — INJECTION
- Status: approved
🇺🇸 Naropin in United States
FDA authorised Naropin on 24 September 1996
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is Naropin approved in United States?
Yes. FDA authorised it on 24 September 1996.
Who is the marketing authorisation holder for Naropin in United States?
FRESENIUS KABI USA holds the US marketing authorisation.